Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
申请人:Mewshaw Eric Richard
公开号:US20050009907A1
公开(公告)日:2005-01-13
This invention provides estrogen receptor modulators having the structure
where R
1
-R
5
are as defined in the specification; or a pharmaceutically acceptable salt thereof.
这项发明提供了具有以下结构的雌激素受体调节剂,其中R1-R5如规范中所定义;或其药学上可接受的盐。
[EN] ARYL-CARBALDEHYDE OXIME DERIVATIVES AND THEIR USE AS ESTROGENIC AGENTS<br/>[FR] DERIVES D'ARYLE-CARBALDEHYDE OXIME ET LEUR UTILISATION COMME AGENTS OESTROGENIQUES
申请人:WYETH CORP
公开号:WO2004103941A3
公开(公告)日:2005-01-20
ARYL-CARBALDEHYDE OXIME DERIVATIVES AND THEIR USE AS ESTROGENIC AGENTS
申请人:Wyeth
公开号:EP1633699A2
公开(公告)日:2006-03-15
US7157491B2
申请人:——
公开号:US7157491B2
公开(公告)日:2007-01-02
ERβ ligands. Part 5: Synthesis and structure–activity relationships of a series of 4′-hydroxyphenyl-aryl-carbaldehyde oxime derivatives
作者:Richard E. Mewshaw、S. Marc Bowen、Heather A. Harris、Zhang B. Xu、Eric S. Manas、Stephen T. Cohn
DOI:10.1016/j.bmcl.2006.11.066
日期:2007.2
A series of 4'-hydroxyphenyl-aryl-carbaldehyde oximes (5b) was prepared and found to have high affinity (4nM) and modest selectivity (39-fold) for estrogen receptor-beta (ERbeta). Substitution of one of the core rings of the scaffold based around these novel ligands further expanded our knowledge in the quest toward achieving high affinity and selectivity for ERbeta. An X-ray co-crystal of structure